Growth Option: UTI Equity

The fund has delivered 3-year annualised return of 27.08 per cent, compared with the category's 21.56 per cent.
     Print Edition: February 2015
Fund tracker: UTI Equity has outperformed its category

The fund has delivered 3-year annualised return of 27.08%, compared with the category's 21.56%.

FUND FACTS
Inception: May 1992
Category: Equity Large Cap
Type: Open-end
AUM: Rs 3963.59 crore
Benchmark Index: S&P BSE 100

WHAT IT COSTS

Nav: Rs 99.00 (G), Rs 83.09 (D)
Min Investment: Rs 5000
Min SIP Amount: Rs 500
Expense Ratio: 2.23% (as on 30/09/2014)
Exit Load: 1% for redemption within 364 days

WHY INVEST IN IT?
One of the oldest Indian funds, UTI Equity has a 22-year history, but its past 7 years have been the most rewarding. Launched as UTI Mastergain, its initial years were nothing to write home about. From being an index-hugger in its initial years, the fund has matured to take substantial active calls that have paid off well in recent years. Oflate, it has added a mid-cap flavour to the portfolio. The fund has been particularly good in bear markets, containing downside to levels far lower than the index in 2001, 2008 and 2011. As a consistent fund that navigates bear markets really well, the fund is tailor-made for a conservative investor.

MEET THE FUND MANAGER
Anoop Bhaskar is head equity at UTI AMC since April, 2007. Before this he has also worked with Sundaram AMC, Franklin Templeton AMC.

(Data and analysis of the fund have been sourced from Value Research)

Youtube
  • Print

  • COMMENT
BT-Story-Page-B.gif
A    A   A
close